ArticleClinical and translational radiation oncology2023

BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial.

Thirza J S Opbroek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.